Hutch News

Hutch News

Stories tagged 'Prostate Cancer'

What's new in prostate cancer: 5 takeaways

‘Many reasons for optimism’ says expert at annual community symposium

May 1, 2018 | by Susan Keown / Fred Hutch News Service

What's new in prostate cancer in 2018? The latest in prostate cancer treatment, screening, survivorship and more.

View story >


How do we bridge gaps in health equity?

Researchers and community members discuss outreach, relationship building at 2018 Pathways to Equity Symposium

April 30, 2018 | By Diane Mapes / Fred Hutch News Service

View story >


Finasteride can reduce prostate cancer risk long term

Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss

March 21, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch public health researcher Dr. Joe Unger used an innovative trial design to confirm finasteride, a drug used to treat enlarged prostate or hair loss in men, has a long-term protective effect against prostate cancer.

View story >


Could a prostate cancer drug save lives from radiation injury?

Early research shows potential for approved hormone-blocking drug to protect from deadly effects of nuclear blast

Jan. 9, 2018 | By Susan Keown / Fred Hutch News Service

A new study used a hormone-blocking prostate cancer drug called degarelix to save the lives of mice exposed to a deadly level of radiation. Could it do the same for people caught in a nuclear blast?

View story >


'Movember' a reminder for dudes to go to the doctor

Growing facial hair in November part of spotlight on men’s health awareness — and the lack thereof

Nov. 28, 2017 | By Diane Mapes / Fred Hutch News Service

Many men loathe going to the doctor — often to their detriment — but the global organization Movember is trying to change that by encouraging men to grow mustaches (or “mo’s”) during November to raise awareness and funds for men’s health research. Fred Hutch's Dr. Pete Nelson weighs in.

View story >


Targeted therapies push metastatic prostate cancer in new directions

Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments

Nov. 14, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Pete Nelson and colleagues found that as hormone-targeting treatments grow more potent, recurrent prostate tumors are more often finding a new way around the drugs.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.